Is Bright Minds Biosciences Inc. (DRUG) a Buy, Sell, or Hold?
NASDAQ : DRUG
Bright Minds Biosciences Inc. — Analyst Ratings
$73.26 USD
-$1.37 (-1.84%)
- Volume
- 212.58K
- Average Volume
- 318.93K
- Market Capitalization
- $717.01M
- P/E Ratio
- -30.42
- Dividend Yield
- 0.00%
- Price Target
- $145.00
- Year High
- $123.75
- Year Low
- $32.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $81.48
Analyst Consensus Summary
Consensus Rating
Sell
4 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-49.5%
vs Current Price
Price Target
$145.00
Average TargetPrice Target Range
Lowest Target
$126.00
-41.9% DOWNSIDE
Average Target
$145.00
Median Estimate
Highest Target
$220.00
-66.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 4
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Pat Trucchio | $145 | $81.02 | 2026-06-02 06:57 AM | 79.0% |
| Chardan Capital | Rudy Li | $80 | $29.02 | 2025-05-07 04:45 AM | 175.7% |
| H.C. Wainwright | Patrick Trucchio | $85 | $38.89 | 2025-01-10 06:09 AM | 118.6% |